| Code | Display |
| 311 |
RESULT CONSISTENT WITH REFERRAL INDICATION |
| 312 |
RESULT PARTIALLY CAUSATIVE OF REFERRAL INDICATION |
| 313 |
GENETIC CAUSE WAS NOT FOUND |
| 314 |
RESULT OF UNCERTAIN SIGNIFICANCE |
| 321 |
VARIANT DETECTED |
| 322 |
VARIANT NOT DETECTED |
| 323 |
FAMILY MEMBER TESTED TO AID INTERPRETATION OF PROBAND’S TEST; NOT INDEPENDENTLY ANALYSED |
| 331 |
VARIANT(S) DETECTED |
| 332 |
VARIANT(S) NOT DETECTED |
| 411 |
ONCOGENIC/LIKELY ONCOGENIC VARIANT DETECTED CONTRIBUTING TO THE SUSPECTED DIAGNOSIS |
| 412 |
ONCOGENIC/LIKELY ONCOGENIC VARIANT DETECTED WHICH CONTRIBUTES TO AN ALTERNATIVE DIAGNOSIS |
| 413 |
NO ONCOGENIC/LIKELY ONCOGENIC VARIANT DETECTED WHICH REDUCES LIKELIHOOD BUT DOES NOT EXCLUDE (DIFFERENTIAL) DIAGNOSIS/DIAGNOSES |
| 421 |
VARIANT DETECTED – WHERE A TARGETED TREATMENT IS AVAILABLE OR WHERE PROGNOSTIC/ACTIONABLE INFORMATION IS PROVIDED |
| 422 |
WILDTYPE RESULT OBTAINED – WHERE THE ABSENCE OF A VARIANT MEANS TARGETED TREATMENT IS NOT AVAILABLE |
| 423 |
WILDTYPE RESULT OBTAINED – WHERE THE ABSENCE OF A VARIANT MEANS TARGETED TREATMENT IS AVAILABLE OR WHERE PROGNOSTIC/ACTIONABLE INFORMATION IS PROVIDED |
| 431 |
TARGET DETECTED AT A LEVEL REQUIRING CLINICAL ACTION |
| 432 |
NO TARGET DETECTED OR TARGET DETECTED BELOW A LEVEL REQUIRING CLINICAL ACTION |
| 961 |
ACTIONABLE PHARMACOGENOMIC VARIANT DETECTED |
| 962 |
NO ACTIONABLE PHARMACOGENOMIC VARIANT DETECTED |
| 971 |
FAILURE |
| 981 |
ONCOGENIC/LIKELY ONCOGENIC VARIANT DETECTED IN GENE NOT ASSOCIATED WITH TUMOUR TYPE/INCIDENTAL FINDING |
| 991 |
OTHER (NOT LISTED) |
| 992 |
CAVEATED RESULT |